HROW CIK: 1360214

Harrow Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
5.08
FY22:
1.71
FY23:
3.84
FY24:
−22.2
FY25:
43.9
Change from FY21 to FY25
millions USD
FY21:
−18.7
FY22:
−1.74
FY23:
−153
FY24:
−33.2
FY25:
−5.46
Change from FY21 to FY25
millions USD
FY21:
51.5
FY22:
54.1
FY23:
127
FY24:
28.5
FY25:
−12.7
millions USD
FY21:
37.9
FY22:
54.1
FY23:
−22.2
FY24:
−26.8
FY25:
25.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.30
FY22:
−0.89
FY23:
2.38
FY24:
−23.8
FY25:
43.0

All amounts in millions USD Data source:SEC EDGAR